Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation.
Jessica C Lal, Chengsheng Mao, Yadi Zhou, Shamone R Gore-Panter, Julie H Rennison, Beth S Lovano, Laurie Castel, Jiyoung Shin, A Marc Gillinov, Jonathan D Smith, John Barnard, David R Van Wagoner, Yuan Luo, Feixiong Cheng, Mina K Chung
October 2022 Cell Rep MedSynopsis of Social media discussions
The discussions demonstrate high enthusiasm and detailed engagement, with many posters stating the significance of using network medicine to identify repurposable drugs like metformin for atrial fibrillation, reflecting the perceived high impact of these findings on medical practice and research.
Agreement
Strong agreementMost discussions express strong support and recognition of the research findings, notably emphasizing the potential of metformin for atrial fibrillation.
Interest
High level of interestPosters display high interest, frequently highlighting the innovative approach and potential clinical implications, using words like 'significantly', 'predicts', and 'identify'.
Engagement
High engagementMany comments reference specific methodologies and implications, such as network analysis and drug repurposing, showing deep engagement with the content.
Impact
High level of impactThe overall tone suggests a belief that this research could have a meaningful impact on treatment strategies and future studies, as seen in phrases like 'potential to transform' and 'significant reduction in risk'.
Social Mentions
YouTube
1 Videos
2 Posts
17 Posts
Blogs
4 Articles
News
24 Articles
Metrics
Video Views
17
Total Likes
21
Extended Reach
159,870
Social Features
48
Timeline: Posts about article
Top Social Media Posts
Posts referencing the article
Metformin as a Potential Drug for Atrial Fibrillation Identified by Network Analysis
On May 2, 2023, the NUPPEESI seminar discussed a study that used transcriptomics-based network medicine to identify metformin as a repurposable drug for atrial fibrillation, highlighting innovative approaches in cardiovascular drug discovery.
-
RT @CellRepMed: Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrilla…
view full postNovember 6, 2022
3
-
Agingdoc
@agingdoc1 (Twitter)@arunkumar3112 Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation Network proximity analysis predicts metformin as repurposed drug for AF➡️Metformin induces directional changes in AF disease module genes. https://t.co/Ygtu11f3QI
view full postNovember 5, 2022
-
Jorge Mario
@piedrux (Twitter)RT @CardioCaribeMx: El uso de #metformina se asocia significativamente con reducción en el riesgo de Fibrilación Auricular, al compararse c…
view full postOctober 27, 2022
1
-
Cardiopaps
@CardioCaribeMx (Twitter)El uso de #metformina se asocia significativamente con reducción en el riesgo de Fibrilación Auricular, al compararse con tratamientos estándar para diabetes.
view full postOctober 27, 2022
1
1
-
advocatefight
@chattyknana (Twitter)Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation: Cell Reports Medicine https://t.co/wemA8pY1RR
view full postOctober 18, 2022
-
dudeabides
@notontherug (Twitter)Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/juA89JNwau
view full postOctober 18, 2022
1
-
Ioan M. Ciumasu
@IoanCiumasu (Twitter)RT @CellRepMed: Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrilla…
view full postOctober 13, 2022
3
-
BioNetPapers
@bionet_papers (Twitter)Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/GxpfwXH4d1
view full postOctober 13, 2022
-
Cardio-Targets
@CardioTargets (Twitter)Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/Rw8EoeTm6D
view full postOctober 13, 2022
-
隠居者のすすめ:老後の明るい歩き方
@docnakaimito (Twitter)RT @CellRepMed: Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrilla…
view full postOctober 12, 2022
3
-
Cell Reports Medicine
@CellRepMed (Twitter)Online now: Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/pZeRVuc7Tt
view full postOctober 12, 2022
6
3
-
كُنت … توته..
@AB_ah505 (Twitter)RT @DRKAMALAYOUB: لا يوجد علاج دوائي شافي للارتجاف الاذيني الا انه وبحسب دراسة مخبرية (لم تختبر بعد سريرياً) وجدت ان لدواء المنظم للسكر مي…
view full postOctober 12, 2022
1
-
الدكتور كمال أيوب
@DRKAMALAYOUB (Twitter)لا يوجد علاج دوائي شافي للارتجاف الاذيني الا انه وبحسب دراسة مخبرية (لم تختبر بعد سريرياً) وجدت ان لدواء المنظم للسكر ميتفورمين خصائص مخبرية قد تمنع الاصابة بالارتجاف وتعالج منه . https://t.co/CYn0B13k7b
view full postOctober 12, 2022
7
1
-
Eugenio Cingolani, MD
@EugenioCingolan (Twitter)Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation https://t.co/VJodbKOUKT
view full postOctober 12, 2022
1
-
AgingResearch
@TheAgingField (Twitter)RT @shashiiyengar: "Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @…
view full postOctober 12, 2022
2
-
J P Fanton
@HealthyFellow (Twitter)RT @shashiiyengar: "Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @…
view full postOctober 12, 2022
2
-
Shashi Iyengar | Accredited Metabolic Health Coach
@shashiiyengar (Twitter)"Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation" @HealthyFellow @dlifein https://t.co/ENmXc8JAbw https://t.co/sd2egp8h9Y
view full postOctober 11, 2022
5
2
Abstract Synopsis
Markley Silva Oliveira-Junior, Ph.D.
@markley_sojr (Twitter)